Skip to main content
Apyx Medical Corp logo

Apyx Medical Corp — Investor Relations & Filings

Ticker · APYX ISIN · US0323472052 LEI · 5299009QZVYUYO082S45 US Manufacturing
Open in API
Filings indexed 969 across all filing types
Latest filing 2019-01-11 Director's Dealing
Country US United States of America
Listing US APYX

About Apyx Medical Corp

https://apyxmedical.com/

Apyx Medical Corporation is an advanced energy technology company that develops, manufactures, and markets innovative products for surgical and cosmetic markets. The company's proprietary Helium Plasma Platform, which is the foundation for its Renuvion® and J-Plasma® brands, utilizes a unique combination of helium plasma and radiofrequency (RF) energy. These systems are designed to deliver controlled energy for the cutting, coagulation, and ablation of soft tissue, with a primary focus on aesthetic procedures for skin tightening and body contouring. Apyx Medical, formerly Bovie Medical, leverages its expertise in energy-based waveforms to provide transformative solutions for surgeons and their patients.

Recent filings

Filing Released Lang Actions
FORM 3
Director's Dealing
2019-01-11 English
APYX_8-K_2019.01.07
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated January 7, 2019, reporting preliminary revenue results for the quarter ending December 31, 2018. It includes a press release as Exhibit 99.1. The text states that the information is furnished pursuant to Item 2.02 (Results of Operations and Financial Condition) and is a press release reporting preliminary quarterly financial results. The document is not a full quarterly or annual report but an initial announcement of quarterly financial results. Therefore, it fits the definition of an Earnings Release (ER). The document length is 3377 characters, which is consistent with a press release rather than a full report. Hence, the classification is ER with high confidence.
2019-01-07 English
Regulatory Filings 2019
Regulatory Filings Classification · 90% confidence The document text appears to be an encoded or encrypted file content, possibly a binary or compressed file represented in ASCII encoding (e.g., uuencoded). There are no readable words, regulatory body mentions, form names, fiscal period dates, or document titles that can be identified. The content does not contain any financial data, report summaries, or announcements. Given the lack of any discernible text or context, it cannot be classified as a specific financial report or announcement. Therefore, the best classification is Regulatory Filings (RNS), which serves as a fallback category for miscellaneous filings that do not fit other categories.
2019-01-02 English
BVX_8-A12B/A_2018.12.31
Regulatory Filings Classification · 100% confidence The document is a Form 8-A/A filed with the SEC, which is used for the registration of certain classes of securities under the Securities Exchange Act of 1934. It is not a financial report, earnings release, or management discussion. The document primarily serves as a regulatory filing to register common stock on NASDAQ. It references the company's Annual Report on Form 10-K for the description of securities but does not contain financial data or report content itself. The document length is short (2877 characters) and is a registration statement, which fits the Regulatory Filings (RNS) category as a general regulatory announcement that does not fit other specific categories.
2018-12-31 English
BVX_FORM 25_2018.12.31
Delisting Announcement
2018-12-31 English
BVX_8-K_2018.12.28
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The key content is the amendment to the company's Certificate of Incorporation, specifically a name change from 'Bovie Medical Corporation' to 'Apyx Medical Corporation'. There are no financial statements or detailed financial data included, only a description of the amendment and an attached Certificate of Amendment. This type of filing is a regulatory announcement of a corporate event rather than a full report or financial disclosure. Given the nature of the content and the form type, this fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous filings that do not fit other specific categories.
2018-12-28 English

Browse filings by year

32 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.